Despite breathtaking medical advances, a central and enduring challenge is ensuring equitable access to healthcare innovations worldwide. The disparity in medical resources between high-income and low-income nations is stark, often described as the “10/90 gap,” where less than 10% of global health research funding addresses diseases that affect 90% of the world’s population. Diseases of poverty, such as tuberculosis and malaria, remain prevalent in regions lacking robust healthcare infrastructure, while cutting-edge treatments for cancer or rare genetic disorders carry prohibitive price tags. Achieving true progress in medicine therefore requires not only scientific brilliance but also a sustained commitment to ethical distribution, affordable pricing models, and the strengthening of primary care systems to ensure that lifesaving discoveries benefit all of humanity, not just a privileged few.
.
